SPY323.50+0.86 0.27%
DIA268.10+0.52 0.19%
IXIC10,672.27+39.28 0.37%

Immunovant shares are trading higher after HC Wainwright & Co. maintained a Buy rating on the company's stock and raised its price target from $34 to $40.

Benzinga · 08/26/2020 10:33